Bengaluru-based telehealth technology startup, Neurosynaptic Communications has secured an undisclosed amount in Series A round of funding from Indian Angel Network (IAN), healthcare-focussed venture fund Healthquad, and Axilor Ventures.
Post investment, members of Healthquad and IAN will join the board of Neurosynaptic.
The funding will be used for international certifications and to expand business in Africa and Southeast Asia. It will also be divested in scaling its operations in India.
Founded in 2002 by Sameer Subhash Sawarkar and Rajeev Kumar, Neurosynaptic offers proven ehealth and mhealth technology solutions that bring together products, partners, and processes in the healthcare delivery ecosystem. It develops a point-of-care diagnostic device capable of performing dry chemistry tests including biochemistry tests, electrolyte tests, HBA1c, etc.
The company aims to enable access of affordable healthcare in rural and semi urban areas, using its cloud-based telemedicine platform called ReMeDi (Remote Medical Diagnostics). The software claims to provide screening and primary diagnosis by connecting patients with doctors.
It also provides more than 35 diagnostic services including physiology, urine and blood chemistry tests along with medical records. It has served more than 50 Mn people in 2000+ villages across India, as per an official statement.